Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 483 entries
View as:

Interferon α for the Therapy of Minimal Residual Disease

Phase: N/A Priority: Normal
NCT ID: NCT02185261 Org: User:
Start: 06/30/14 End: 06/30/21 Due: 06/30/22

Treatment of Posttraumatic Swelling and Pain With Zhi Kang Capsule

Phase: N/A Priority: Normal
NCT ID: NCT03363971 Org: User:
Start: 03/13/17 End: 03/13/18 Due: 03/13/19

Changes of Pelvic Floor Functions in Women at Different Postpartum Time

Phase: N/A Priority: Normal
NCT ID: NCT03921463 Org: User:
Start: 04/30/19 End: 04/30/20 Due: 04/30/21

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

Phase: N/A Priority: Normal
NCT ID: NCT05408897 Org: User:
Start: 01/01/22 End: 04/30/28 Due: 04/30/29

IVIg Plus Low Dose rhTPO for ITP in Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT05634824 Org: User:
Start: 01/01/23 End: 01/01/23 Due: 01/01/24

Zanubrutinib and Eltrombopag as Second-line Treatment in Adults With Primary Immune Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT05369377 Org: User:
Start: 06/01/22 End: 12/30/25 Due: 12/30/26

Effect of PEFLOW on PFM Function Recovery of Postpartum Women

Phase: N/A Priority: Normal
NCT ID: NCT05218239 Org: User:
Start: 11/02/21 End: 06/30/23 Due: 06/30/24

Modified Video-assisted Thoracoscopic Surgery (VATS) Lobectomy for Early-stage Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT01337037 Org: User:
Start: 04/30/11 End: 12/31/16 Due: 12/31/17

New Therapy for Advanced Stage Leukemia After Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01455272 Org: User:
Start: 07/31/09 End: 03/31/15 Due: 03/31/16

Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT06395220 Org: User:
Start: 06/05/24 End: 01/01/26 Due: 01/01/27

Activity Trackers for Monitoring During Rehabilitation After Total Knee Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT03368287 Org: User:
Start: 01/01/18 End: 01/31/19 Due: 01/31/20

CD147-CAR T Cells for Relapsed/Refractory T Cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05013372 Org: User:
Start: 01/31/23 End: 01/01/25 Due: 01/01/26

Low-dose IL-2 ( Interleukin-2) Treatment in Macrophage Activation Syndrome（MAS）

Phase: N/A Priority: Normal
NCT ID: NCT02569463 Org: User:
Start: 06/30/14 End: 06/30/18 Due: 06/30/19

Rapid DFLC Response Predict CHR in AL Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT06627309 Org: User:
Start: 10/26/24 End: 07/01/26 Due: 07/01/27

Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06682884 Org: User:
Start: 11/15/24 End: 05/31/27 Due: 05/31/28

Compare Different Cervical Anterior Discectomy Procedures by After Procedure Sagittal Alignment on Radiograph

Phase: N/A Priority: Normal
NCT ID: NCT03360409 Org: User:
Start: 02/01/18 End: 06/01/20 Due: 06/01/21

VATS Major Lung Resection for Chinese Early-stage Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01707888 Org: User:
Start: 09/30/14 End: 06/30/17 Due: 06/30/18

Study of 6b11-OCIK Injection Treatment in Patients With Recurrent Drug-resistant Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03542669 Org: User:
Start: 08/03/18 End: 12/30/23 Due: 12/30/24

Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)

Phase: N/A Priority: Normal
NCT ID: NCT04817046 Org: User:
Start: 02/19/21 End: 12/31/24 Due: 12/31/25

The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT03304288 Org: User:
Start: 10/11/17 End: 02/28/21 Due: 02/28/22

Appropriate Strategy of Surgical Treatment in Ischemic Diabetic Foot

Phase: N/A Priority: Normal
NCT ID: NCT04709887 Org: User:
Start: 01/01/17 End: 01/01/24 Due: 01/01/25

A Study of Orelabrutinib in Patients With ITP

Phase: N/A Priority: Normal
NCT ID: NCT05124028 Org: User:
Start: 12/01/21 End: 06/01/22 Due: 06/01/23

Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma

Phase: N/A Priority: Normal
NCT ID: NCT04042597 Org: User:
Start: 07/18/19 End: 12/31/21 Due: 12/31/22

Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT.

Phase: N/A Priority: Normal
NCT ID: NCT06946602 Org: User:
Start: 05/20/25 End: 10/31/27 Due: 10/31/28

Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment

Phase: N/A Priority: Normal
NCT ID: NCT06850506 Org: User:
Start: 09/01/24 End: 09/01/25 Due: 09/01/26